Table 2 |
|||||
|
Clinical comparison of patients with rheumatoid arthritis (RA) expressing high* and low levels of survivin |
|||||
| Survivin high, erosive RA (n = 27) |
P |
Survivin low, erosive RA (n = 61) |
P |
Survivin low, non-erosive RA (n = 42)† |
|
|
|
|||||
| Survivin levels (pg/ml) |
|||||
| Blood |
1180 ± 309 |
<0.0001 |
97 ± 9 |
0.013 |
127 ± 5 |
| Synovial fluid |
1039 ± 523 |
0.016 |
132 ± 4 |
n.s. |
124 ± 2 |
| Disease duration (years) |
15.5 ± 2.4 |
n.s. |
13.6 ± 1.2 |
0.0002 |
8.3 ± 1.4 |
| Age (years) |
58 ± 3 |
n.s. |
60 ± 2 |
0.05 |
53 ± 3 |
| Rheumatoid factor-positive (n) |
25 |
n.s. |
53 |
<0.0001 |
10 |
| C-reactive protein (mg/l) |
45 ± 9 |
0.035 |
29 ± 5 |
n.s. |
39 ± 7 |
| White blood cell count (× 109/ml) |
|||||
| Blood |
8.7 ± 0.6 |
0.038 |
7.2 ± 0.3 |
n.s. |
7.1 ± 0.3 |
| Synovial fluid |
10.8 ± 1.9 |
n.s. |
11.2 ± 2.9 |
n.s. |
13.1 ± 2.8 |
|
|
|||||
|
Continuous parameters are presented as the mean ± standard error of the mean. n.s., not significant. *Level of survivin above 300 pg/ml was considered 'high'. †One patient having a high survivin level is excluded. |
|||||
|
Bokarewa et al. Arthritis Res Ther 2005 7:R349 doi:10.1186/ar1498 |
|||||